The CDC has now activated six emergency responses for pathogens in 2026 — the latest a level 3 response to a record dengue outbreak in Florida — a pace that underscores how many infectious disease threats are landing on hospitals and public health agencies at once.
From a fatal new spillover in France to a bird flu outbreak left uncontained on a U.S. mink farm, the past several weeks have handed infection prevention and clinical leaders a dense cluster of public health concerns.
Four to track:
1. The CDC declared a level 3 emergency over Florida’s record dengue outbreak.
The CDC issued a Level 3 emergency response for dengue outbreaks in Florida and the Republic of the Marshall Islands, its eighth emergency activation of the year, MedPage Today reported Oct. 22. Florida officials have recorded 745 dengue cases in 2026, 425 of them locally acquired and most concentrated in the Tampa area — the largest dengue outbreak in the continental U.S. since 1935, according to MedPage Today.
The clinical footprint is significant: Forty-seven percent of cases required hospitalization, which the CDC said may point to under-reporting of milder infections.
“Given the widespread presence of Aedes aegypti mosquitoes and with recent hurricane-related rainfall, continued domestic transmission remains a concern,” Chris Braden, MD, acting director of the CDC’s National Center for Emerging and Zoonotic Infectious Diseases, wrote in an email shared with MedPage Today.
No dengue vaccine is licensed in the U.S., and experts anticipate the disease will become endemic. For Gulf Coast health systems, that makes dengue a diagnosis to keep on the differential for feverish patients, including those with no travel history, and a potential pressure on inpatient capacity during peak mosquito season. The CDC’s other 2026 activations included measles, Ebola, New World screwworm, hantavirus and cyclospora.
2. France confirmed the first known human case of Shamonda virus. The patient died.
French authorities confirmed a Shamonda virus infection in a patient in Lyon, France, who died in early October, ABC News reported Oct. 22. It is the first documented human detection of a pathogen previously considered non-transmissible to people.
The patient was severely immunocompromised and was being treated for a serious illness at Hospices Civils de Lyon, according to France’s Agriculture Ministry. The ministry said brain complications seen before death were “very likely linked” to the infection, though investigators are still working to confirm whether the virus caused the death and how it was acquired.
French authorities said no risk to the general population has been identified to date, and the World Health Organization and European CDC are investigating.
3. Bird flu has gone uncontained at a Utah mink farm for about two months.
An H5N1 bird flu outbreak has spread unchecked since at least mid-August at a mink farm west of Provo, Utah, and the state has not ordered a cull or sustained monitoring of farmworkers, ProPublica reported Oct. 23. Seven captive mink in Utah had tested positive on a U.S. Department of Agriculture dashboard.
The strain — the same one that has moved through U.S. poultry since 2022 and dairy cattle since 2024 — has killed two people who caught it from infected animals, with no confirmed human-to-human spread, according to ProPublica. Researchers flag mink as a particular concern because their airways carry many of the same cell receptors found in human noses and throats, making the animals a plausible mixing vessel for a more transmissible strain.
The USDA said it has no species-specific authority or funding to depopulate mink, and that Congress would have to appropriate it; the federal poultry culling program has cost more than $1 billion since 2022.
Utah stopped actively monitoring mink workers under a 2025 arrangement that lets agriculture officials share outbreak data only if health officials do not track worker health. The gap matters clinically: conjunctivitis appears in more than 90% of human H5N1 cases and should prompt testing in patients with animal exposure.
4. CDC and the Department of Homeland Security are routing travelers from Ebola-affected countries through enhanced screening.
The CDC will require foreign travelers entering the U.S. to certify they have not been in the Democratic Republic of the Congo in the prior three weeks, The Hill reported Oct. 22. The requirement builds on earlier rules barring travelers, including U.S. citizens, who had been in the DRC within 21 days of departure.
The Department of Homeland Security has handled flight routing and “do not board” orders under the broader Ebola entry restrictions.
The measure responds to a Bundibugyo-strain Ebola outbreak that the World Health Organization reported had surpassed 9,000 confirmed cases and 4,000 confirmed deaths as of Oct. 11. The outbreak has begun crossing borders: Kenya has recorded nine cases with 134 contacts in quarantine, and Nigeria is tracing 44 contacts. An initial 70,000 doses of the Ervebo vaccine have been released to the DRC from the global stockpile.
The combination of a new U.S. entry requirement and documented airport-linked spread puts travel-history screening and isolation readiness back on the agenda for emergency departments.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
